Catalyst Wire Dossier Catalyst Wire Dossier

BEBT-701

· BeBetter Med Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BEBT-701, covering 2026-01-26 to 2026-01-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BEBT-701 in Patients With Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol(LDL-C) [Phase 1, Phase 2]

See pricing